Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy.
Sheng T, Sundar R, Srivastava S, Ong X, Tay ST, Ma H, Uchihara T, Lian BSX, Hagihara T, Kong MS, Xu C, Ho SWT, Huang KK, Tan ALK, Ng MSW, Toh J, Ng CSY, Nasca V, Pircher CC, Randon G, Giordano S, Corso S, Lum JHY, Zhao JJ, Teh M, So JBY, Sabella G, Prabhakar S, Lee J, Ng MCH, Shitara K, Gasparello J, Fassan M, Pietrantonio F, Tan P.
Sheng T, et al. Among authors: sundar r.
Gut. 2025 Oct 30:gutjnl-2024-334667. doi: 10.1136/gutjnl-2024-334667. Online ahead of print.
Gut. 2025.
PMID: 41167802